课题基金 / 基金详情

Induction of apoptosis against cytokine-producing urological cancer

Induction of apoptosis against cytokine-producing urological cancer
诱导细胞凋亡对抗产生细胞因子的泌尿系癌症
批准号:
10671493
负责人:
TACHIBANA Masaaki
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

TACHIBANA Masaaki的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在探讨针对细胞因子产生细胞的癌症基因治疗。首先,我们成功地建立了产生细胞因子的人泌尿系统癌细胞,包括肾癌(KU-19-20)和膀胱癌(KU-19-19)作为靶模型。这些细胞已显示分泌多种细胞因子,如粒细胞集落刺激因子(G-CSF)、粒细胞巨噬细胞集落刺激因子(GM-CSF)、白细胞介素-6(IL-6)和IL-8。在此基础上,我们进一步研究了核因子κ B(NFκB)是否能够调控细胞的生长和凋亡。当IκB稳定型cDNA(已知是NFκB抑制剂)用腺病毒载体转染到细胞中时,这些细胞中的几种细胞因子的产生被基因递送显著抑制。值得注意的是,通过基因治疗也观察到细胞凋亡的显著诱导。这些结果表明,NFκB活化可维持细胞活力,并调节产精氨酸癌细胞中细胞因子的产生,因此这些体外实验支持临床前体内研究的基本原理,以证明对已建立肿瘤的生长抑制。
英文摘要
This study was designed to investigate cancer gene therapy against cytokine producing cells. Firstable, we succeeded establishment of cytokine producing human urological cancer cells including kidney (KU-19-20) and bladder (KU-19-19) as a target model. These cells have been shown to secrete a variety of cytokines such as granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interleiukin-6 (IL-6) and IL-8. Then we investigated whether the cell growth and apoptosis of cytokine-producing cells can be regulated by nuclear factor kappa B (NFκB). When IκB stable form cDNA (which is known to be the NFκB inhibitor) was transfected into the cells with adenovirus vector, the production of several cytokines was significantly suppressed in these cells by the gene delivery. Notably, the significant induction of apoptosis was also observed by the gene therapy. These results suggest that NFκB activation maintains the cell viability as well as regulates cytokine production in cytokine-producing cancer cells and therefore these in vitro experiments support a rationale for preclinical in vivo studies to demonstrate growth inhibition in established tumors.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Sumitomo M, Tachibana M et al.,: "Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme(ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells"Br J Cancer. 81:2. 277-86 (1999)
Sumitomo M、Tachibana M 等人:“IL-1ra 基因过度表达上调白细胞介素 1β 转换酶 (ICE) 基因表达:癌细胞 IL-1β 抗性的可能机制”Br J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Makoto Sumitomo,Masaaki Tachibana et al: "Induction of apoptosis cytokine-producing bladder cancer cells by adenovirus-mediated IkBa overexpression" Human Gene Therapy. 10. 37-47 (1999)
Makoto Sumitomo、Masaaki Tachibana 等人:“通过腺病毒介导的 IkBa 过度表达诱导产生细胞因子的膀胱癌细胞凋亡”人类基因疗法。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tachibana M et al: "G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review."Cytokines Cell Mol. Ther. 4:2. 113-20 (1998)
Tachibana M 等人:“人类膀胱癌中 G-CSF 的产生及其促进自分泌生长的能力:综述。”Cytokines Cell Mol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tumor specific immunotherapy using dendritic cells generated from allogeneic peripheral stem cell.
  • 批准号:
    14370520
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.22万
  • 财政年份:
    2002
  • 负责人:
    TACHIBANA Masaaki
  • 依托单位:
HLA restricted tumor specific antigen epitope pulsed autologous dendritic cell vaccine treatment for hormone refractory prostate cancer
  • 批准号:
    12671557
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.56万
  • 财政年份:
    2000
  • 负责人:
    TACHIBANA Masaaki
  • 依托单位:
Establish mentofthe minimally invasive treatments based on biological characteristics for advanceduro logical cancers.
  • 批准号:
    07407046
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 资助金额:
    $14.21万
  • 财政年份:
    1995
  • 负责人:
    TACHIBANA Masaaki
  • 依托单位:
Studies on objective indicator for predicting malignant potential of bladder cancer.
  • 批准号:
    04454409
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 资助金额:
    $3.9万
  • 财政年份:
    1992
  • 负责人:
    TACHIBANA Masaaki
  • 依托单位:
国内基金
海外基金
基于TLR4/NF-κB通路与耐药基因调控探讨温阳化气汤治疗耐碳青霉烯鲍曼不动杆菌肺炎的作用机制
  • 批准号:
    JCZRLH202600367
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
桦木酸联合黄芪甲苷调控BMP2-Nrf2-NFκB改善糖尿病合并腰椎间盘突出症的机制研究
  • 批准号:
    JCZRLH202601480
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
贝母素乙通过激活NF-κB信号通路调控线粒体功能障碍介导三阴型乳腺癌细胞焦亡的作用机制研究
  • 批准号:
    2026JJ80203
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    易念
  • 依托单位:
草鱼NF-κB p50与IL-10启动子的结合特性及其调控效应